TAZOCIN 2.25 G.

Kraj: Izrael

Język: angielski

Źródło: Ministry of Health

Składnik aktywny:

PIPERACILLIN AS SODIUM 2 G/VIAL; TAZOBACTAM SODIUM 0.25 G/VIAL

Dostępny od:

NEOPHARM LTD

Kod ATC:

J01CR05

Forma farmaceutyczna:

POWDER FOR SOLUTION FOR INJECTION

Droga podania:

I.V

Wyprodukowano przez:

WYETH PIPER. DIV.OF WYETH HOLDINGS CORP.

Grupa terapeutyczna:

PIPERACILLIN AND ENZYME INHIBITOR

Wskazania:

Antibiotic for the treatment of systemic and/or local bacterial infections caused by susceptible organisms. Tazocin in combination with an aminoglycoside, is indicated for suspected bacterial infections in neutropenic adults or children above 2 years. Appendicitis complicated by rupture with peritonitis and/or abscess formation in children aged 2-12 years.

Data autoryzacji:

2010-06-01